The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy

Oncogene

Volumn 27, Issue 20, 2008, Pages 2833-2842

  Lee, D Y ^a   Sugden, B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Autophagy; EBV; LMP1

Indexed keywords

LATENT MEMBRANE PROTEIN 1; LIGAND;

ARTICLE; AUTOPHAGY; B LYMPHOCYTE; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; CYTOSTASIS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; LYSOSOME; NEOPLASM; NONHUMAN; ONCOGENE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

AUTOPHAGY; B-LYMPHOCYTES; CELL LINE, TUMOR; HERPESVIRUS 4, HUMAN; HUMANS; ONCOGENES; VIRAL MATRIX PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 42949162045     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210946     Document Type: Article

References (36)

1. Baehrecke EH. (2005). Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 6: 505-510.
2. Baichwal VR, Sugden B. (1987). Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol 61: 866-875.
3. Bornkamm GW, Hammerschmidt W. (2001). Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 437-459.
4. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. (1998). Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci USA 95: 8245-8250.
5. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E et al. (1996). Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol 16: 7098-7108.
6. Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, Gires O et al. (2005). Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24: 1711-1717.
7. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W. (2003). Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63: 2982-2989.
8. Gires O, Kohlhuber F, Kilger E, Baumann M, Kieser A, Kaiser C et al. (1999). Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 18: 3064-3073.
9. Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R et al. (1997). Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16: 6131-6140.
10. Gregory CD, Rowe M, Rickinson AB. (1990). Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71(Part 7): 1481-1495.
11. Humme S, Reisbach G, Feederle R, Delecluse HJ, Bousset K, Hammerschmidt W et al. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci USA 100: 10989-10994.
12. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N et al. (2000). A ubiquitin-like system mediates protein lipidation. Nature 408: 488-492.
13. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T et al. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
14. Kavathas P, Bach FH, DeMars R. (1980). Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci USA 77: 4251-4255.
15. Kaye KM, Izumi KM, Kieff E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90: 9150-9154.
16. Kaykas A, Sugden B. (2000). The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 19: 1400-1410.
17. Kaykas A, Worringer K, Sugden B. (2002). LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. J Virol 76: 11551-11560.
18. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W. (1997). Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 16: 6478-6485.
19. Kilger E, Kieser A, Baumann M, Hammerschmidt W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17: 1700-1709.
20. Knutson JC, Yee D. (1987). Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem 164: 44-52.
21. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I et al. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
22. Lam N, Sandberg ML, Sugden B. (2004). High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. J Virol 78: 1657-1664.
23. Lam N, Sugden B. (2003). CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 15: 9-16.
24. Lee J, Sugden B. (2007). A membrane leucine heptad contributes to LMP1's trafficking, signaling and transformation. J Virol 81: 9121-9130.
25. Martin J, Sugden B. (1991). Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol 65: 3246-3258.
26. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD et al. (1998). A protein conjugation system essential for autophagy. Nature 395: 395-398.
27. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399.
28. Neuhierl B, Feederle R, Hammerschmidt W, Delecluse HJ. (2002). Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci USA 99: 15036-15041.
29. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T et al. (2005). Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307: 593-596.
30. Ravikumar B, Duden R, Rubinsztein DC. (2002). Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11: 1107-1117.
31. Sandberg M, Hammerschmidt W, Sugden B. (1997). Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol 71: 4649-4656.
32. Tanida I, Ueno T, Kominami E. (2004). Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 279: 47704-47710.
33. Tassa A, Roux MP, Attaix D, Bechet DM. (2003). Class III phosphoinositide 3-kinase - Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. Biochem J 376: 577-586.
34. Taylor GS, Long HM, Haigh TA, Larsen M, Brooks J, Rickinson AB. (2006). A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells. J Immunol 177: 3746-3756.
35. Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N et al. (1999). Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286: 300-303.
36. Yoshimori T. (2004). Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 313: 453-458.